S.S. Guo, M.P. Sawicki, Molecular and genetic mechanisms of tumorigenes in multiple endocrine neoplasia type-1. Mol. Endocrinol. 15, 1653–1664 (2001)
Article CAS PubMed Google Scholar
G. Effraimidis, U. Knigge, M. Rossing, P. Oturai, Å.K. Rasmussen, U. Feldt-Rasmussen, Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs). Semin. Cancer Biol. 79, 141–162 (2022)
Article CAS PubMed Google Scholar
R.V. Thakker, P.J. Newey, G.V. Walls et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97, 2990–3011 (2012)
Article CAS PubMed Google Scholar
B. Niederle, A. Selberherr, D.K. Bartsch et al. Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome – an international consensus statement. Neuroendocrinology 111, 609–630 (2021)
Article CAS PubMed Google Scholar
G.M. Doherty, Multiple endocrine neoplasia type 1: duodenopancreatic tumors. Surg. Oncol. 12, 135–143 (2003)
M.A. Kouvaraki, S.E. Shapiro, G.J. Cote et al. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J. Surg. 30, 643–653 (2006)
M. Falconi, B. Eriksson, G. Kaltsas et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 103, 153–171 (2016)
Article CAS PubMed Google Scholar
L. Camera, S. Paoletta, C. Mollica et al. Screening of pancreaticoduodenal endocrine tumours in patients with MEN 1: multidetector-row computed tomography vs. endoscopic ultrasound. Radio. Med. 116, 595–606 (2011)
C. Barbe, A. Murat, B. Dupas et al. Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumors in multiple endocrine neoplasia type-1. Dig. Liv Dis. 44, 228–234 (2012)
I.D. Nagtegaal, R.D. Odze, D. Klimstra et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 76, 182–188 (2020)
C. Cappelli, U. Boggi, S. Mazzeo et al. Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours. Eur. Radio. 25, 751–759 (2015)
E. Belousova, G. Karmazanovsky, A. Kriger et al. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades. Clin. Radio. 72, 150–158 (2017)
F. Salahshour, M.M. Mehrabinejad, A. Zare Dehnavi et al. Pancreatic neuroendocrine tumors (pNETs): the predictive value of MDCT characteristics in the differentiation of histopathological grades. Abdom. Radio. 45, 3155–3162 (2020)
S. Chiloiro, F. Lanza, A. Bianchi, G. et al. Pancreatic neuroendocrine tumors in MEN-1 disease: a monocentric longitudinal and prognostic study. Endocrine 60, 362–367 (2018). https://doi.org/10.1007/S12020-017-1327-0
V. Ramundo, M. Del Prete, V. Marotta et al. Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours. Clin. Endocrinol. 80, 850–855 (2014)
A. Faggiano, R. Modica, F. Lo Calzo et al. Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors < 2 centimeters. J. Clin. Endocrinol. Metab. 105, dgz007 (2020). https://doi.org/10.1210/clinem/dgz007
S. Lastoria, F. Marciello, A. Faggiano et al. Role of 68Ga-DOTATATE PET/CT in patients with multiple nedocrine neoplasia type 1 (MEN1). Endocrine 52, 488–494 (2016). https://doi.org/10.1007/s12020-015-0702y
N. Lévy-Bohbot, C. Merle, P. Goudet et al. Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry. Gastroenterol. Clin. Biol. 28, 1075–1081 (2004)
F. Tonelli, G. Fratini, G. Nesi et al. Pancreatectomy in multiple endocrine neoplasia type-1 related gastrinomas and pancreatic endocrine neoplasia. Ann. Surg. 244, 61–70 (2006)
Article PubMed PubMed Central Google Scholar
R. Casadei, C. Ricci, G. Taffurelli et al. Is total pancreatectomy as feasible, safe, efficacious and cost-effective as pancreaticoduodenectomy? A single center, prospective, observational study. J. Gastrointest. Surg. 20, 1595–1607 (2016). https://doi.org/10.1007/s11605-016-3201-4
留言 (0)